Sangamo Therapeutics Inc Equity-NMS: SGMO

$0.66 0.04 (April 5, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$0.6223
Open :$0.76
Today's high :$0.77
Today's low :$0.59
52W low :$0.304
52W high :$3.179
EPS(TTM): :-0.49
Shares O/S :224.71 M
Market cap :148.31 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Sangamo Therapeutics Inc $0.66 -0% - 148.31M

Frequently Asked Questions

What is the share price of Sangamo Therapeutics Inc today?

Sangamo Therapeutics Inc (SGMO) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Sangamo Therapeutics Inc

Sangamo Therapeutics, Inc. is a genomic medicines company that is developing medicines for neurological diseases. The Company's neurology preclinical development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases, and development of novel engineered adeno-associated virus (AAV) capsids to deliver its therapies to the intended neurological targets. The Company's zinc finger epigenetic regulators are ideally suited to potentially address neurological disorders and its capsid discovery platform is expanding delivery beyond intrathecal delivery capsids, including in the central nervous system. Its clinical-stage product candidates are Isaralgagene civaparvovec, also known as ST-920, its wholly-owned gene therapy product candidate for the treatment of Fabry disease, and TX200, its wholly-owned CAR-Treg cell therapy product candidate for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation.